References
- Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006; 20: 76–89
- Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19: 623–9
- Schagen SB, Van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999; 85: 640–50
- Tralongo P, Di Mari A, Ferrau’ F. Cognitive impairment, aromatase inhibitors, and age. J Clin Oncol 2005; 23: 4243
- Schilder CM, Schagen SB. Effects of hormonal therapy on cognitive functioning in breast cancer patients: A review of the literature. Minerva Ginecol 2007; 59: 387–401
- Wise PM. Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 2006; 138: 831–5
- Chen D, Wu CF, Shi B, Xu YM. Tamoxifen and toremifene cause impairment of learning and memory function in mice. Pharmacol Biochem Behav 2002; 71: 269–76
- Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004; 26: 955–69
- Paganini-Hill A, Clark LJ. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 2000; 64: 165–76
- Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 2004; 21: 364–71
- Ernst T, Chang L, Cooray D, Salvador C, Jovicich J, Walot I, et al. The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 2002; 94: 592–7
- Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 2004; 13: 61–6
- Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 2007; 14: 995–8
- Meulen EF, Schmand B, van Campen JP, de Koning SJ, Ponds RW, Scheltens P, et al. The seven minute screen: A neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry 2004; 75: 700–5
- Van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998; 90: 210–8
- Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21(Pt 1)1–16
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–76
- Frojdh K, Hakansson A, Karlsson I. The Hopkins Symptom Checklist-25 is a sensitive case-finder of clinically important depressive states in elderly people in primary care. Int J Geriatr Psychiatry 2004; 19: 386–90
- Smets EM, Garssen B, Bonke B, de Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315–25
- Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999; 55: 189–99
- van den Burg W, Saan RJ, Deelman BG. 15-woordentest. Provisional Manual. University Hospital, Department of Neuropsychology, Groningen 1985
- Wechsler D. Wechsler Memory Scale: Revised. Psychological Corporation, New York 1987
- Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 2002; 73: 126–33
- Wechsler D. WAIS-III Nederlandstalige Bewerking. Swets & Zeitlinger, Lisse 2000, Technische Handleiding
- Hammes J. De Stroop kleur-woord test. Handleiding. Swets & Zeitlinger, Lisse 1978
- Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271–6
- Alpherts W, Aldenkamp AP. FePsy: The iron psyche. Instituut voor Epilepsiebestrijding, Heemstede 1994
- Lezak M. Neuropsychological assessment. Oxford University Press, New York 2004
- Van der Elst W, van Boxtel MP, Van Breukelen GJ, Jolles J. Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc 2006; 12: 80–9
- Schmand B, Lindeboom J, van Harskamp F. De Nederlandse Leestest voor Volwassenen. Swets & Zeitlinger, Lisse 1992